We have previously revealed the protective role of CD8 ؉ T cells in host defense against Histoplasma capsulatum in animals with CD4
T cell activation. Taken together, our results revealed that phagocyte apoptosis in the Histoplasma-infected host is associated with CD8
؉ T cell activation and that immunization with apoptotic phagocytes containing heat-killed Histoplasma efficiently evokes a protective CD8 ؉ T cell response. These results suggest that employing apoptotic phagocytes as antigen donor cells is a viable approach for the development of efficacious vaccines to elicit strong CD8 ؉ T cell as well as CD4 ؉ T cell responses to Histoplasma infection.
Histoplasma capsulatum is an opportunistic fungal pathogen that threatens the life of immune-compromised individuals, especially those infected with HIV (8) . Upon entry into the respiratory system, the fungus transforms into yeast cells and is phagocytosed by the macrophage. The yeast cells of Histoplasma reside and replicate primarily in the phagosome of macrophages (16) . Gamma interferon (IFN-␥) produced by CD4 ϩ and CD8 ϩ T cells can activate macrophages to produce reactive oxygen species and nitric oxide for fungal clearance (3, 14, 16, 31) . A previous depletion study established the vital role of CD4 ϩ T cells in clearing Histoplasma in intranasal infection of wild-type mice (3) . Depletion of CD8 ϩ T cells or a deficiency in major histocompatibility complex class I (MHC-I), on the other hand, has little effect on fungal clearance (3, 5) . However, the protective role of CD8 ϩ T cells is prominent in infection of mice with MHC-II deficiency (14) , demonstrating that CD8 ϩ T cells can be protective against histoplasmosis in the absence of functional CD4 ϩ T cells. In HIV-infected individuals whose CD4 ϩ T cell responses gradually decline, the CD8 ϩ T cells become the major effectors defending against opportunistic infections. Thus, developing vaccines that aim to induce functional CD8 ϩ T cell immune responses would be valuable.
Vaccines designed for nonviral pathogens often focus on eliciting CD4
ϩ T cell and B cell immune responses (15, 24) . The CD8 ϩ T cell response receives relatively little attention. Recently, increasing evidence demonstrated that exogenous or nonviral antigens can be presented on MHC-I molecules to prime CD8 ϩ T cell responses, processes referred to as "crosspresentation" and "cross-priming" (12) . Exogenous antigens coupled with heat shock protein (25) , exosomes (29) , immune complexes (20) , and latex beads (22) all can be cross-presented to prime CD8 ϩ T cells. Immunizing mice with antigen-containing dead cells or with dead cell-pulsed dendritic cells is a well-recognized strategy in the development of cancer vaccines to elicit strong CD8 ϩ T cell responses (6, 9) . In their studies of infectious diseases, Albert et al. were the first to report that apoptotic monocytes deliver influenza antigens to dendritic cells and trigger CD8 ϩ T cell immune responses (1) . Nonviral intracellular pathogens such as Salmonella and Mycobacterium induce macrophage apoptosis, and the apoptotic cell blebs shuttle the bacterial antigens to uninfected bystander antigenpresenting cells to cross-prime CD8 ϩ T cells (21, 33) . We previously showed that sensitized CD8 ϩ T cells were restimulated in vitro by dendritic cells that acquired Histoplasma antigens through phagocytosis of heat-killed Histoplasma-containing apoptotic macrophages (14) . In addition, Winau et al. showed that subcutaneously immunizing mice with apoptotic vesicles prepared from Mycobacterium bovis BCG-ovalbumininfected macrophages not only induces adoptively transferred OT-1 CD8 ϩ T cell division and IFN-␥ production in vivo but also protects mice from tuberculosis (28) . The results of these studies together raise the possibility that a similar strategy aiming to cross-prime strong CD8 ϩ T cell responses could be applied to develop fungal vaccines.
Here ) mice were originally obtained from the Jackson Laboratory (Bar Harbor, MA) and bred at the Laboratory Animal Center, National Taiwan University College of Medicine. CD11c-DTR transgenic mice (10) were provided by A. DeFranco (University of California at San Francisco, San Francisco, CA). All mice used were of the C57BL/6 background and were housed in sterilized cages fitted with filter cage tops and fed with sterilized food and water. Mice at 8 to 10 weeks of age were used in all the experiments in this study. The present study was carried out in strict accordance with the recommendations in the Guidebook for the Care and Use of Laboratory Animals (4a). The protocol was approved by the Committee on the Ethics of Animal Experiments of the National Taiwan University College of Medicine (permit 20040318).
Abs and medium. Allophycocyanin (APC)-rat-anti-mouse CD8 (clone 53-6.7), fluorescein isothiocyanate (FITC)-rat-anti-mouse CD4 (clone RM4-5), phycoerythrin (PE)-hamster-anti-mouse CD3 (clone 145-2C11), FITC-rat-anti-mouse B220 (clone RA3-6B2), PE-rat-anti-mouse F4/80 (clone BM8), PE-rat-antimouse Gr-1 (clone RB6-8C5), and PE-rat IgG1 isotype (for immunofluorescence staining) antibodies (Abs) were purchased from eBioscience (San Diego, CA). FITC-and PE-hamster-anti-mouse CD11c (clone HL3) were from BD Pharmingen (San Diego, CA). Purified hamster-anti-CD3 (clone 145-2C11), purified hamster-anti-mouse CD28 (clone 37.51), and PE-rat-anti-mouse IFN-␥ (clone XMG1.2) antibodies were from BioLegend (San Diego, CA). PE-mouse-antihuman granzyme B (clone MHGB04) antibody was from Caltag Laboratories (Burlingame, CA). RPMI 1640 medium (Gibco BRL, Gaithersburg, MD) was supplemented with 10% heat-inactivated fetal calf serum (Biological Industries, Kibbutz Beit Haemek, Israel), 2 mM L-glutamine, 0.1 mM nonessential amino acid, 1 mM sodium pyruvate, 100 U/ml penicillin, 100 g/ml streptomycin, 5 ϫ 10 Ϫ5 M 2-mercaptoethanol, and 25 mM HEPES buffer. The supplemented medium was used as RPMI 1640 complete medium. All of the supplements except serum were obtained from Gibco-BRL. ]) in 40 l of RPMI 1640 medium were injected into the trachea through a 29-gauge insulin syringe. The skin was sutured, and the mice were kept under a warming lamp until they reawakened. For subcutaneous infection, 2,000,000 (2 ϫ 10 6 ) Histoplasma yeasts were suspended in 100 l of RPMI 1640 medium. Mice were anesthetized, and each side of the base of the tail was inoculated with 50 l of Histoplasma suspension through a 29-gauge insulin syringe. Heat-killed Histoplasma yeast cells were prepared by heating fresh prepared yeasts at 65°C for 120 min.
Intracellular IFN-␥ and granzyme B staining. Single-cell suspensions of the inguinal or mediastinal lymph nodes were prepared. One million lymph node cells in RPMI 1640 complete medium were cultured with 1 ϫ 10 5 heat-killed Histoplasma yeast cells and 1 ϫ 10 6 irradiated (1,000 rads) spleen cells from naive mice for 24 h. At 6 h before harvest, monensin (Sigma-Aldrich, St. Louis, MO) (2 M) was added to the culture to block intracellular protein transport. Cells were collected and stained to reveal surface CD4 and CD8 and intracellular IFN-␥ as previously described (13) . For granzyme B staining, the cells were first incubated with 2.4G2 Ab (BioLegend) directed against mouse Fc␥ II/III receptors before staining with PE-anti-granzyme B monoclonal antibodies (Mabs) was performed as previously described (14) . PE-mouse IgG1 was used as an isotype control.
Inguinal lymph node cells harvested from CD11c-DTR transgenic mice were stimulated with plate-bound anti-mouse CD3 (0.5 g/ml) and anti-mouse CD28 (0.5 g/ml) MAbs for 5 h in the presence of monensin. Cells were collected and stained to reveal surface CD4 and CD8 and intracellular IFN-␥ as described above.
Single-cell preparations from lung and subcutaneous injection sites. The subcutaneous tissues were collected at day 5 after subcutaneous inoculation of Histoplasma. A portion of the tissue was snap-frozen in liquid nitrogen. Another portion was cut into small pieces in 500 l of Dulbecco's phosphate-buffered saline (PBS) (Biological Industries, Kibbutz Beit Haemek, Israel) with scissors and treated with 5 mg/ml of type I collagenase (Sigma-Aldrich) at 37°C for 1 to 1.5 h. The debris was removed by filtration through nylon mesh. Lungs were harvested at day 4 after intratracheal inoculation and ground between two frosted glass slides. A single-cell suspension was obtained by passing the suspension through cotton wadding packed in a Pasture pipette.
Immunofluorescence staining for confocal microscopy and flow cytometric analysis. Subcutaneous tissues from the area at the base of the tail where mice were immunized were cryopreserved. The sections were fixed in acetone for 10 min and dried in air. The slides were blocked for 20 min with Dulbecco's PBS (Biological Industries) containing 5% inactivated fetal calf serum and stained with PE-anti-F4/80, PE-anti-Gr-1, PE-anti-CD3, FITC-anti-CD11c, or FITC-anti-B220 MAb at 4°C in a humidified chamber in the dark overnight. After washing was performed, Hoechst 33258 reagent was added and allowed to stain for 3 to 5 min. The sections were viewed under a confocal microscope (Leica, Germany). The single cells isolated from subcutaneous tissue prepared as described above were stained with FITC-anti-CD11c, PEanti-F4/80, or PE-anti-Gr-1 at 4°C for 30 min. Cells were acquired with a FACSCanto system and analyzed with FACSDiva software (Becton Dickinson, San Diego, CA).
TUNEL staining (in situ cell death detection). The cryosections were fixed with 4% paraformaldehyde (Merck, Darmstadt, Germany) for 20 min. The sections were then treated with 0.1% Triton X-100 (Sigma-Aldrich) at 4°C for 5 min and incubated with a terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) reaction mixture containing FITC-dNTP (Roche, Basel, Switzerland) at 37°C in the dark for 1 h. After being washed with PBS, the slides were stained with PE-anti-F4/80 or PE-anti-Gr-1. The sections were examined under a confocal microscope.
For flow cytometric analysis, cells isolated from subcutaneous tissues and lungs were first stained with PE-anti-F4/80 or PE-anti-Gr-1 MAbs at 4°C for 30 min followed by the addition of the TUNEL reaction mixture containing FITC-dNTP and incubated at 37°C in the dark for 1 h. The cells were acquired with a FACSCanto system and analyzed with FACSDiva software.
Preparation of and immunization with apoptotic phagocytes containing heatkilled Histoplasma. Wild-type or ␤ 2 m Ϫ/Ϫ mice were injected intraperitoneally with 4% thioglycolate (Difco). To obtain macrophages, peritoneal cells were harvested 4 days later. The cells (2 ϫ 10 6 ) were allowed to adhere in RPMI 1640 medium overnight. Nonadherent cells were removed by washing with prewarmed Hanks' balanced salt solution (HBSS). Twenty million heat-killed Histoplasma yeast cells were added to the monolayer. After 2 h of incubation at 37°C, the monolayer was washed with prewarmed HBSS to remove free Histoplasma yeast cells. The culture was left at 37°C overnight. Apoptosis was induced by treatment with lipopolysaccharide (LPS) (Sigma-Aldrich) (1 g/ml) at 37°C for 4 h, followed by addition of 5 mM ATP (Sigma-Aldrich) for another 45 min. The cells became nonadherent. They were harvested by gentle pipetting and washed with RPMI 1640 medium two times. One hundred percent of the cells were apoptotic as confirmed by a TUNEL assay. Apoptotic macrophages were suspended in 50 l of RPMI 1640 medium and injected subcutaneously into mice on two sides of the base of the tail (1 ϫ 10 6 cells/injection) by two injections administered 2 weeks apart.
To obtain neutrophils, peritoneal cells were harvested 4 h after thioglycolate injection. Seventy-five percent of the cells were Gr1 ϩ . Ten million of the heatkilled Histoplasma yeasts were added to culture containing 1 ϫ 10 6 neutrophils (multiplicity of infection [MOI ϭ 10]). After overnight incubation, the cells were exposed to UV irradiation at 350 mJ/cm 2 to induce apoptotic cell death (7). Ninety percent of the cells were apoptotic after the treatment as confirmed by annexin V (BD Pharmingen) staining and flow cytometry analysis. Apoptotic cells were suspended in 50 l of RPMI 1640 medium and injected subcutaneously into mice on two sides of the base of the tail (1 ϫ 10 6 cells/injection) by two injections administered 2 weeks apart.
To prepare CFSE-labeled apoptotic macrophages, thioglycolate-elicited peritoneal macrophages were allowed to take up heat-killed Histoplasma as described previously. Before induction of apoptosis, CFSE (Invitrogen, Carlsbad, CA) at a final concentration of 5 M was added to the macrophage culture and let stand for 5 min. The monolayers were washed free of CFSE and treated with LPS and ATP to induce apoptosis. The detached cells were collected, washed, and injected subcutaneously into mice.
Injection of apoptosis inhibitor. Boc-D-FMK (pan-caspase inhibitor; SigmaAldrich) (0.2 mol) or Z-FA-FMK (control peptide; Sigma-Aldrich) (0.2 mol) was dissolved in 10 l of dimethyl sulfoxide (DMSO) for storage and diluted with 190 l of sterilized Dulbecco's PBS immediately before injection. Mice were injected intraperitoneally with Boc-D-FMK or Z-FA-FMK at the time of intratracheal infection with Histoplasma and daily afterwards until the day of the experiment (2) .
In vivo cell depletion. To deplete CD11c ϩ dendritic cells, CD11c-DTR transgenic mice and wild-type control mice were injected with 0.1 g of diphtheria toxin-200 l PBS (Sigma-Aldrich) intraperitoneally 1 day befor and 2 days after immunization with apoptotic pMac (HK Hc). Diphtheria toxin treatment depleted Ͼ86% of the CD11c ϩ in the spleen as determined by flow cytometry at 3 to 4 days after the last dose of diphtheria toxin. To deplete CD4 ϩ and/or CD8 ϩ T cells, mice were injected intraperitoneally with concentrated supernatants from hybridoma GK1.5 (anti-CD4) or 2.43 (anti-CD8) or both at 1 day before and twice weekly after challenge with Histoplasma. The protein concentrations of concentrated hybridoma supernatants were 4.0 mg of GK1.5 and/or 2.5 mg of 2.43 per injection. The treatment depleted Ͼ95% of CD4 ϩ and Ͼ95% of CD8 ϩ T cells in the spleen as determined by flow cytometry at 3 to 4 days after the last dose of the antibody treatment. Determination of fungal burden. Mice immunized subcutaneously with live Histoplasma, apoptotic pMac (HK Hc), or RPMI 1640 medium were challenged intravenously with 2.5 ϫ 10 4 live Histoplasma yeast cells at day 5 after the second immunization. Spleens were harvested and homogenized at day 10 after challenge; the homogenates were plated on cysteine-blood-glucose agar and incubated at 30°C. Mycelial colonies were counted at 10 to 14 days after incubation. Fungal burdens in the spleens were expressed as the log 10 value of CFU per spleen as previously described (14) .
Lungs from mice treated with caspase inhibitor or control peptide or left untreated were collected at day 10 after intratracheal inoculation of 2 ϫ 10 5 Histoplasma yeast cells. The lungs were homogenized, and the homogenates were plated on cysteine-blood-glucose agar and incubated for 10 to 14 days. The CFU level in the control mice was assigned a value of 100%, and the CFU levels in the experimental groups were compared to the control level. The data are presented as percent CFU change.
H and E staining. The cryosections were fixed with 4% paraformaldehyde and stained with 0.1% hematoxylin and 2% eosin for 5 min.
Statistics. The comparisons between multiple groups were analyzed by oneway analysis of variance (ANOVA) followed by a post hoc Tukey test, performed using Prism 4.0 software (GraphPad Software). The comparisons between two groups were analyzed by Student's t test. The level of statistical significance was defined as P Ͻ 0.05.
RESULTS

Apoptotic macrophages as antigen donors are efficient in delivering Histoplasma antigen to induce functional CD8
؉ and CD4 ؉ T cell activation in vivo. In previous in vitro studies, we showed that apoptotic pMac (HK Hc) can deliver fungal antigens contained within them to dendritic cells, which in turn cross-present Histoplasma antigens to activate sensitized CD8 ϩ T cells (14) . Here we extended the study and immunized mice with apoptotic macrophages that had taken up Histoplasma yeasts. IFN-␥ production as determined by intracellular cytokine staining was used as an indicator of functional activation of both CD8 ϩ and CD4 ϩ T cells (13) . The results presented in Fig. 1A show that apoptotic pMac (HK Hc) at 2 ϫ 10 6 and 4 ϫ 10 6 efficiently induced activation of functional CD8 ϩ and CD4 ϩ T cells. Although the numbers of IFN-␥-producing CD8 ϩ and CD4 ϩ T cells did not reach the levels seen with the mice receiving live Histoplasma, they were significantly higher than those seen with mice receiving heat-killed Histoplasma alone (Fig. 1A) (P Ͻ 0.001 for CD8
ϩ and P Ͻ 0.05 for CD4 ϩ ). Moreover, CD8
ϩ T cells expressed not only IFN-␥ but also granzyme B (Fig. 1B) . These results indicate that heat-killed Histoplasma antigens contained within apoptotic macrophages are efficiently delivered to cross-prime CD8
ϩ T cells and activate CD4 ϩ T cells in vivo. The results presented in Fig. 2A further revealed that immunization with apoptotic macrophages mixed with heat-killed Histoplasma apoptotic (pMac ϩ HK Hc), viable macrophages with ingested heat-killed Histoplasma pMac (HK Hc), apoptotic macrophages (apoptotic pMac), or viable macrophages (pMac) alone did not induce T cell responses at a level comparable to that of immunization with apoptotic pMac (HK Hc). It is noteworthy that apoptotic pMac simply mixed with heatkilled Histoplasma before injection (apoptotic pMac ϩ HK Hc) did not induce a strong CD8 ϩ or CD4 ϩ T cell response ( Fig. 2A) , suggesting that Histoplasma antigens must be contained within apoptotic macrophages for antigen presentation. Moreover, immunization with apoptotic neutrophils containing heat-killed Histoplasma [apoptotic pNeu (HK Hc)] was as efficient as apoptotic pMac (HK Hc) at inducing a strong CD8 ϩ or CD4 ϩ T cell response (Fig. 2B) , which indicates that, after Histoplasma yeasts are taken up by the phagocytes, the fungal antigen contained within the phagocytes can be presented to activate CD8 ϩ and CD4 ϩ T cells. Interestingly, immunizing mice with apoptotic pMac (HK Hc) lacking MHC-I molecules (␤ 2 m Ϫ/Ϫ ) activated CD8 ϩ T cells as efficiently as wild-type macrophages did (Fig. 2C) , indicating that apoptotic cells serve as antigen donor cells to deliver Histoplasma antigens rather than as antigen-presenting cells in the immunized host.
CD8 ؉ and CD4 ؉ T cells make equal contributions to host defense after immunization with apoptotic macrophages containing heat-killed Histoplasma. Next, mice immunized with apoptotic pMac (HK Hc) were challenged with Histoplasma intravenously. Figure 3A shows that immunized mice had significantly lower fungal burdens in the spleen compared with unimmunized mice (CM; P Ͻ 0.01) at day 10 after challenge. Depleting either the CD8 ϩ population T cell or the CD4 ϩ T cell population in mice immunized with apoptotic pMac (HK Hc) at the time of challenge significantly increased the fungal 3B) . These results, together with those presented in Fig. 1 and  2 , demonstrate that immunization with apoptotic pMac (HK Hc) effectively induces activation of protective CD8 ϩ cells and that the contribution of CD8 ϩ T cells to host defense against histoplasmosis is comparable to that of CD4 ϩ T cells.
Reduction of macrophage apoptosis is due to iNOS deficiency decreases CD8
؉ T cell activation. To explore the relationship between macrophage cell death and CD8 ϩ T cell activation, iNOS Ϫ/Ϫ and wild-type mice were intratracheally infected with Histoplasma. Figure 4A shows that the number of apoptotic F4/80 ϩ cells in the lungs of infected iNOS Ϫ/Ϫ mice was significantly lower than in the wild-type mice (P Ͻ 0.05). Coinciding with lower numbers of apoptotic F4/80 ϩ cells in the lungs, the percentage of IFN-␥-producing CD8 ϩ T cells was also significantly lower in iNOS Ϫ/Ϫ mice than in wild-type mice (Fig. 4B) (P Ͻ 0.05) . Interestingly, the CD4 ϩ T cell response in iNOS Ϫ/Ϫ mice was not affected by the reduction in numbers of apoptotic F4/80 ϩ cells (Fig. 4B) . The results of the macrophage phagocytosis assay and stimulation of CD8 ϩ T cells with anti-CD3 and anti-CD28 antibodies showed that macrophages and CD8
ϩ T cells from iNOS Ϫ/Ϫ mice were functionally comparable to those of wild-type mice (data not shown). Additionally, bone marrow-derived dendritic cells from iNOS Ϫ/Ϫ mice expressed more MHC-I and CD40 but fewer MHC-II molecules on the surface than cells from the wild-type mice after infection with Histoplasma yeasts (data not shown). These observations excluded the possibility of an intrinsic defect of macrophages or of the antigen presentation functions of dendritic cells in the iNOS Ϫ/Ϫ mice affecting CD8 ϩ T cell activation. These results together indicated that iNOS, possibly through production of nitric oxide, is the cause of macrophage apoptotic cell death and that macrophage death is important for CD8 ϩ T cell activation in cases of pulmonary infection by Histoplasma.
Inhibition of apoptotic cell death by a caspase inhibitor decreases CD8
؉ T cell responses and exacerbates pulmonary histoplasmosis. To further demonstrate the importance of apoptosis of antigen donor cells in activation of CD8 ϩ T cell responses after pulmonary infection, we treated infected mice with the caspase inhibitor Boc-D-FMK (26) . The number of apoptotic F4/80 ϩ cells seen at the early phase after infection was significantly (P Ͻ 0.05) reduced in mice treated with Boc-D-FMK compared with the number seen after treatment with (23) (Fig. 5A) . Interestingly, and consistent with what we observed in iNOS Ϫ/Ϫ mice, the CD8 ϩ T cell response but not the CD4 ϩ T cell response was reduced in mice whose macrophage apoptosis was inhibited (Fig. 5B) . Notably, Boc-D-FMK treatment resulted in a higher fungal burden than Z-FA-FMK treatment (Fig. 5C) . These results together indicate that macrophage apoptosis is critical for CD8 ϩ T cell activation and subsequent fungal clearance in Histoplasma infection. hoc Tukey test ( ** , P Ͻ 0.01; **** , P Ͻ 0.001; NS, not significant).
FIG. 4. iNOS deficiency reduces F4/80
ϩ cell apoptosis and weakens CD8 ϩ T cell response in pulmonary histoplasmosis. Wild-type and iNOS Ϫ/Ϫ mice were infected intratracheally with 2 ϫ 10 5 live Histoplasma. (A) At day 5 after infection, lung cells were isolated and stained with PE-anti-F4/80 antibody and TUNEL reagents containing FITC-dNTP. F4/80 ϩ TUNEL ϩ apoptotic cells were analyzed by flow cytometry. Data shown represent the means Ϯ SD of the total numbers of apoptotic F4/80 ϩ cells determined for 3 mice used in 3 independent experiments. (B) At day 10 after infection, the mediastinal lymph nodes were harvested and cells were stained with PE-anti-IFN-␥ and FITC-anti-CD4 or APC-anti-CD8 antibodies. Data shown represent the means Ϯ SD of the percentages of IFN-␥-producing CD8 ϩ or CD4 ϩ T cells in the total CD8 ϩ or CD4 ϩ T cell population determined for 6 mice used in 3 independent experiments. Cells harvested from uninfected wild-type mice served as controls. The P values were obtained by comparing the results determined for pairs of groups (linked by a bracket) using Student's ( Fig. 6A) were mostly Gr-1 ϩ and F4/80 ϩ cells, some CD11c ϩ cells, and very few B220 ϩ and CD3 ϩ cells (Fig. 6B and C) . A single-cell suspension prepared from the digested subcutaneous tissues contained mainly Gr-1 ϩ (68.9%) and F4/80 ϩ (18.9%) cells (Fig. 6B) , confirming that granulocytes and macrophages represent the major cell populations at the site of subcutaneous inoculation. It is noteworthy that both infiltrating granulocytes and macrophages became apoptotic (Fig. 6D) and that granulocytes and macrophages constituted 77.6% and 17.2%, respectively, of the total apoptotic cell populations at day 5 after inoculation (Fig. 6E) . Moreover, subcutaneous inoculation of iNOS Ϫ/Ϫ mice with viable Histoplasma induced CD4 ϩ T cell but not CD8 ϩ T cell activation (Fig. 6F) . Together, these results point to the importance of apoptotic cell death during the early phase of Histoplasma infection in inducing protective CD8 ϩ T cell responses and fungal clearance.
CD11c
؉ cells are required for CD8 ؉ T cell cross-priming. We further investigated the role of host dendritic cells in presenting antigens contained within apoptotic macrophages to activate CD8 ϩ T cells. Mice were subcutaneously immunized with CFSE-labeled apoptotic pMac (HK Hc). Five days after immunization, CFSE-labeled apoptotic macrophage cytoplasmic materials were found inside CD11c ϩ cells in the draining lymph nodes (Fig. 7A) . Furthermore, depleting CD11c ϩ cells in CD11c-DTR transgenic mice by diphtheria toxin treatment before inoculation of apoptotic pMac (HK Hc) significantly reduced the percentage of IFN-␥-producing CD8 ϩ by 6.5-fold compared with the results seen with wild-type mice treated with diphtheria toxin (Fig. 7B) . These results indicate that host CD11c ϩ dendritic cells at the inoculation site take up the fungal antigens contained within the apoptotic macrophages after immunization with apoptotic pMac (HK Hc) and migrate to the draining lymph nodes to cross-prime CD8 T cells.
DISCUSSION
Histoplasma capsulatum is a facultative intracellular fungal pathogen of the macrophage (16) . It has long been recognized that the macrophage serves as the host cell as well as the effector cell for Histoplasma yeasts (17, 30, 31) . The results of our in vitro studies showed that ingestion of Histoplasma yeasts triggers macrophage apoptotic cell death and that the apoptotic macrophage serves as a Histoplasma antigen donor to cross-prime CD8 ϩ T cells (14) . In this study, we showed that immunization with apoptotic pMac (HK Hc) or apoptotic pNeu (HK Hc) activates both CD8 ϩ and CD4 ϩ T cells. Remarkably, immunization with apoptotic macrophages or neutrophils mixed with killed yeasts (apoptotic pMac ϩ HK Hc or apoptotic pNeu ϩ HK Hc) or with viable macrophages containing killed yeasts [pMac (HK Hc)] does not efficiently activate CD8 ϩ and CD4 ϩ T cells ( Fig. 2A and B) . In infection by Histoplasma, iNOS deficiency and apoptosis inhibitor treatment decrease the number of apoptotic macrophages and weaken CD8 ϩ T cell but not CD4 ϩ T cell responses. The results of our study demonstrate that apoptosis of phagocytes is an immune mechanism that is of critical importance to CD8 ϩ T cell activation in histoplasmosis. Infection-induced apoptosis is a newly recognized immune function important to antimicrobial immunity, especially in (Fig. 4) . These findings together demonstrate that iNOS induction contributes to macrophage death. On the fungus side, both the yeast cell wall component ␣-(1,3)-glucan and the secreted calcium-binding protein (CBP) have been previously identified as Histoplasma virulence factors (19) . Silencing ␣-(1,3)-glucan biosynthesis reduces the ability of Histoplasma yeast to cause macrophage-like P388D1 cell death (18) , and a cbp1-null mutant lost the ability to kill P388D1 cells in culture in vitro (11) . Although it is not clear whether Histoplasma yeast cell ␣-(1,3)-glucan and secreted CBP cause macrophages to produce nitric oxide, it appears that a built-in system exists in the interaction between the fungus and macrophage to ensure macrophage death, which we showed is essential to CD8 ϩ T cell cross-priming. We have showed in the present report that macrophages and granulocytes in subcutaneous tissues as well as macrophages in the lungs constitute the major cell populations during the early phase of subcutaneous and pulmonary infection, respectively, and undergo apoptosis (Fig. 6 and 4) . The percentages of infiltrating CD3
ϩ T cells, in contrast, are low at early time points (data not shown). Allen and Deepe analyzed the apoptotic cell populations in the lungs of Histoplasma-infected mice at days 7, 14, and 21 after infection (2), which represent the activation and contraction phases of T cell response (13) , and found that apoptotic CD3 ϩ T cells were the major apoptotic cells (2, 13) . Their study showed that inhibition of apoptosis is associated with elevation of interleukin-4 (IL-4) and IL-10 levels and that the release of those cytokines exacerbates the severity of infection. We found that administration of Boc-D-FMK at the beginning of infection reduced the number of apoptotic macrophages by about 50% at day 4 and dampened the subsequent CD8 ϩ T cell but not the CD4 ϩ T cell response ( Fig. 5A and B ). This causal relationship demonstrates that macrophage apoptotic cell death at the early phase of infection, the time when antigen processing, presentation, and cross-presentation take place, modulates the protective CD8 ϩ T cell response. Our results and those of Allen and Deepe together stress that apoptosis at the antigen processing and presentation phases as well as the T cell contraction phase is critical for protective immune responses in histoplasmosis.
It has been reported that immunization of mice with apoptotic vesicles prepared from BCG-OVA-infected macrophages induces adoptively transferred OT-1 CD8 ϩ T cell activation and that such mice are protected against challenge by Mycobacterium tuberculosis (28) . Injection of apoptotic antigenpulsed dendritic cells induces both humoral and cellular immune responses and confers protection against Toxoplasma gondii presented as an oral challenge (4) . In this study, we showed that immunization with apoptotic pMac (HK Hc) induces activation of functional CD8 ϩ and CD4 ϩ T cells and that CD8
ϩ and CD4 ϩ T cells contribute equally to efficient clearance of Histoplasma. These results together suggest that apoptotic cells delivering antigens to elicit functional and protective CD8 ϩ and CD4 ϩ T cell responses can be used to immunize against intracellular bacterial and parasitic as well as fungal pathogens.
After subcutaneous injection of live Histoplasma, there is massive granulocyte infiltration and 60 to 80% of the cells are apoptotic at days 3 to 7 after inoculation ( Fig. 6A to E) . Apoptotic neutrophils are as efficient as apoptotic macrophages at delivering Histoplasma antigens to activate CD8 ϩ and CD4 ϩ T cells (Fig. 2B) . Granulocyte infiltration in the spleen after systemic infection or in the lungs after intratracheal infection is not as pronounced as it is in the subcutaneous tissues after local infection (S.-H.H. personal observation). The contribution of apoptotic neutrophils to cross-presentation in infection through the natural routes may not be as important as that of the macrophages. However, utilizing
FIG. 7. CD11c
ϩ cells are critical for CD8 ϩ T cell activation after immunization with apoptotic macrophages containing Histoplasma. (A) CFSE-labeled peritoneal macrophages were allowed to ingest heat-killed Histoplasma before LPS and ATP treatment. Wild-type mice were inoculated subcutaneously with apoptotic pMac (HK Hc). Five days after inoculation, the inguinal lymph nodes were snap-frozen and subjected to cryosectioning. The sections were stained with PEanti-CD11c MAb and viewed under a confocal microscope. The arrowheads point to CFSE-labeled macrophage cytoplasmic materials that were contained within CD11c ϩ cells. (B) Wild-type mice and CD11c-DTR transgenic mice were intraperitoneally administered 100 ng of diphtheria toxin at days Ϫ1 and 2 and inoculated subcutaneously with apoptotic pMac (HK Hc) at day 0. Draining lymph node cells were harvested at day 5 and stimulated with suboptimal concentrations of plate-bound anti-CD3 (0.5 g/ml) and anti-CD28 (0.5 g/ml) antibodies for 5 h. IFN-␥-producing CD8 ϩ T cells were analyzed by flow cytometry. Data shown represent the means Ϯ SD of the results obtained with 4 mice used in 3 independent experiments. Lymph node cells from wild-type mice inoculated with medium only (CM) served as controls. *** , P Ͻ 0.005 by Student's t test. 
